monthly healthcare review april 2016 - bioenterprise · pdf filecompany, ubs investment bank,...
TRANSCRIPT
Monthly Healthcare Review
April 2016
Company NameLast Financing
DateHQ Location Description
Last
Financing
Size
(Millions)
Lead Manager
GeNeuro (GNRO) 15-Apr-16 Geneva,
Switzerland
Developer of pharmaceutical products for disorders of the nervous system associated with
the expression of pathogenic proteins of human endogenous retroviral origin (HERV),
including the diseases multiple sclerosis and schizophrenia.
36.67 Bryan, Garnier &
Co, Societe
Generale
Aeglea BioTherapeutics
Holdings (AGLE)
7-Apr-16 Austin, TX Provider of drugs for the treatment of cancer. The company engages in clinical
development of engineered human enzymes and developing therapeutic enzymes for
oncology. Its lead drug candidate AEB1102 is being developed as an enzyme replacement
therapy in patients with the inborn error metabolism hyperargininemia that is caused by
Arginase I deficiency.
50.00 BMO Capital
Markets Corp,
Cowen and
Company, UBS
Investment Bank,
Wells Fargo
Securities
The following table includes the medical devices, biotechnology, pharmaceuticals, and healthcare IPO pricings, filings and withdrawals announced over the previous month.
IPOs
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 1
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
NeuMoDx Molecular 29-Apr-16 Ann Arbor, MI Early Stage VC Provider of in-vitro molecule testing facilities in hospital and clinical
reference laboratories.
20.00 Undisclosed
Vital Metrix 28-Apr-16 Nashville, TN Angel Developer of a hemodynamic monitoring system for patient treatment.
The company provides a cardiac output measurement system which
helps to provide data to a patient's cardiologist while the patient is home
and allows for the better treatment of congestive heart failure.
0.08 Undisclosed
Synedgen 28-Apr-16 Claremont, CA Angel Developer and provider of life saving products and therapies that
encourage wound healing, reduce complications of tissue damage and
inflammation, prevent infection by drug-resistant bacteria and remove
the biofilms in which they thrive.
6.00 Andrew Miller
Sirnaomics 28-Apr-16 Gaithersburg, MD Angel Developer of novel targeted therapeutics for critical human diseases. The
company provides therapeutics to reduce scar formation and increase the
tensile strength of skin from burns, chronic skin ulcers caused by
pressure, venous stasis and diabetes mellitus.
10.00 Undisclosed
Sienna
Biopharmaceuticals
28-Apr-16 Westlake Village,
CA
Early Stage VC Developer of medical dermatology products. The company is focused on
the discovery, clinical development and commercialization of products in
aesthetics and dermatology based on scientific breakthroughs that
improves patient outcomes and physicians' practice of medicine.
34.00 ARCH Venture
Partners
NeuroChaos Solutions 27-Apr-16 Austin, TX Early Stage VC Developer and provider of products to objectively identify and monitor
Traumatic Brain Injury (TBI). The company develops products that
provide information regarding the presence of TBI, its severity and the
recovery period. Its technology can be used in emergency rooms and by
sports and military physicians, providing an objective test on which to
base clinical decisions and patient-recovery plans.
0.21 Undisclosed
Cytrellis Biosystems 27-Apr-16 Boston, MA Early Stage VC Developer of medical devices focused on dermatology, scar reduction
and aesthetic medicine.
Undisclosed Merz
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 2
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
LifeWalker 26-Apr-16 San Diego, CA Angel Manufacturer and seller of assistive mobility products for people who
need assistance with walking as a result of aging, trauma, spine or joint
replacement surgery, musculoskeletal, brain, nervous system and other
gait disorders.
Undisclosed Undisclosed
FLX Bio 26-Apr-16 South San
Francisco, CA
Early Stage VC Developer of cancer immunotherapies. The company specializes in the
research, development and commercialization of anti-cancer therapeutics
agents that combat cancer by reversing tumor immunosuppression.
50.00 The Column Group,
Topspin Partners,
Kleiner Perkins
Caufield & Byers
Dominion Aesthetic
Technologies
26-Apr-16 San Antonio, TX Angel Owner and operator of a company focused on the development of
medical devices. The company focuses on the commercialization of new
technologies in the fields of plastic and reconstructive surgeries for the
medical community.
0.20 Undisclosed
CrossBay Medical 26-Apr-16 San Rafael, CA Angel Designer, developer, manufacturer and distributer of medical devices like
gentleheels, biomatress covers and ID links for women and children.
0.01 Undisclosed
Camras Vision 26-Apr-16 Durham, NC Angel Developer of an ophthalmic medical device. The company offers
patented new technology for glaucoma patients.
1.30 Charlotte Angel
Fund, other
undisclosed
BioFactura 26-Apr-16 Frederick, MD Angel Developer of a platform for the production of biodefense drugs,
biological drugs and vaccines. The company develops biodefense drugs
against smallpox and Ebola, novel medicines for cancer, and biosimilars
for autoimmune and infectious diseases using StableFast, a
biomanufacturing platform.
1.80 Jeffrey Hausfield
Neurodyn Life Sciences 25-Apr-16 Vancouver, Canada Angel Developer of bioactives for neuroprotection and the early treatment of
neurological diseases. The company identifies bioactive compounds
within historically-proven natural treatments while validating therapeutic
candidates and also developing treatments for Parkinson’s, Alzheimer’s,
ALS and chronic nerve pain.
0.39 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 3
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Naya Health 25-Apr-16 Redwood City, CA Seed Round Developer of a breast pump technology for nursing women. Its system
fulfills the needs of working moms by providing a portable breast pump
that can be used in both the workplace and home.
4.00 Tandem Capital,
Bojiang Capital
ENT Biotech Solutions 25-Apr-16 Detroit, MI Early Stage VC Developer of medical devices for the otolaryngology market to remove
tonsils and soft tissue.
1.10 Undisclosed
Cruzar Medsystems 25-Apr-16 Braintree, MA Early Stage VC Developer of medical technology and devices. The company is designing
a catheter that allows physicians to cross obstructive lesions without
capital equipment.
0.80 Undisclosed
Augmedix 25-Apr-16 San Francisco, CA Early Stage VC Provider of a telemedicine charting service. The company caters to the
healthcare industry and offers telemedicine charting services for
documentation.
17.00 Redmile Group
Wicab 22-Apr-16 Middleton, WI Early Stage VC Operator of a biomedical engineering company. The company offers
BrainPort V100, which is a non-surgical assistive device intended for
orientation, mobility, object identification, and spot reading by
individuals who are blind with no useful vision.
2.40 Undisclosed
Trainer Rx 22-Apr-16 Walnut Creek, CA Angel Operator of a medical software company that is used for designing
solutions to meet the demands of healthcare professionals treating
musculoskeletal injury.
1.38 Undisclosed
NetMedi 22-Apr-16 Helsinki, Finland Seed Round Developer of communication software for the healthcare sector. The
company provides Kaiku, which enables secure online communication
between patients and care personnel.
0.94 Metsola Ventures
H-Source 22-Apr-16 Spokane, WA Angel Provider of an online hospital marketplace platform. The company
provides a web-based platform for hospitals to buy/sell/transfer supplies
and equipment with each other.
0.78 Undisclosed
ChartSpan Medical
Technologies
22-Apr-16 Greenville, SC Angel Provider of an online personal health record platform. The company
allows users to also carry around patient data on the mobile devices such
as X-rays and other medical images and choose whether or not to share
them.
3.20 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 4
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
BioBeats 22-Apr-16 London, United
Kingdom
Early Stage VC Developer of a software combining biometric monitoring with music.
The company offers a mobile software that creates music generated from
the user’s heartbeat and helps in stress management.
2.28 White Cloud Capital
410 Medical Innovation 22-Apr-16 Durham, NC Angel Provider of a hand-operated fluid delivery device that allows medical
providers to deliver a large volume of fluid through traditional IV access
to patients during emergency situations.
0.93 Undisclosed
TripleCare 21-Apr-16 Long Island City,
NY
Early Stage VC Provider of physician services, telemedicine equipment and proprietary
software to nursing facilities. The company provides acute hospital-level
care to patients residing in nursing facilities using state-of-the-art
telemedicine technology.
2.50 Undisclosed
Silk Biomaterials 21-Apr-16 Lomazzo, Italy Early Stage VC Developer of a regenerative medical technology platform using silk. The
company is developing silk-based biomaterials designed to help
regenerate human tissues, including in the vascular system, and then to
degrade and be safely absorbed in the body.
7.78 Principia SGR
BreezoMeter 21-Apr-16 Haifa, Israel Accelerator/
Incubator
Provider of an online platform and a mobile application which allows
gathering of data from various sensors worldwide to provide a real-time,
location-based map of air pollution levels for health and wellness use.
Undisclosed Undisclosed
Rhythm Diagnostic
Systems
20-Apr-16 San Francisco, CA Angel Developer of a wearable health tracking device which can record,
measure and transmit oxygen saturation, body temperature, respiration
rate and heart rate.
4.64 Undisclosed
PeptiMimesis 20-Apr-16 Illkirch, France Seed Round Owner and operator of a biopharma company. The company offers to
develops transmembrane therapeutic peptides that enables the
identification of peptidomimetic candidates interfering with the hetero-
and/or the homodimerization of target receptors.
1.33 Alsace Capital
Medicenna Therapeutics 20-Apr-16 Vancouver, Canada Angel Operator of a clinical-stage immunotherapy research firm. The company
develops cytokines for targeted treatment of cancer, autoimmune disease
and fibrosis.
0.80 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 5
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Capture Vascular 20-Apr-16 Telluride, CO Early Stage VC Manufacturer and designer of medical devices for thrombectomy. The
company offers two products to address health issues related to coronary
artery disease, peripheral arterial disease, deep vein thrombosis and
pulmonary embolism.
2.59 Undisclosed
1Mg 20-Apr-16 New Delhi, India Early Stage VC Operator of a pharmacy discovery platform. The company provides a
portal enabling users to locate pharmaceutical providers within their local
areas. The site also provides one-click information about medicines
which have the same composition as prescribed, but which can be
cheaper.
16.00 Maverick Capital
PNA Innovations 19-Apr-16 Woburn, MA Angel Provider of customized reagents for targeting DNA and RNA. The
company develops a nucleic acid platform which is a synthetic nucleic
acid called gamma peptide nucleic acid (γPNA) for regulation of gene
expression and manipulation of nucleic acid structures and functions.
2.58 MAG Ventures
Innoblative Designs 19-Apr-16 Chicago, IL Angel Developer of a radio frequency ablation applicator. The company
develops a medical device which allows surgeons and interventionalists to
coagulate and ablate soft tissue beds intra-operatively.
1.18 Undisclosed
G-Therapeutics 19-Apr-16 Ecublens,
Switzerland
Early Stage VC Developer of an implantable neuro-stimulation system (INS). The
company provides a neuro-stimulation system to rehabilitate patients
suffering from neurological disorders such as spinal cord injury.
40.00 Life Sciences
Partners, INKEF
Capital, Gimv,
Wellington Partners
Everly Well 19-Apr-16 Austin, TX Seed Round Provider of a suite of at-home regulatory-compliant diagnostic tests that
provides results online.
2.50 Undisclosed
Eagledream Health 19-Apr-16 Rochester, NY Angel Developer of healthcare analytics software. The company develops
software that enables physicians and healthcare teams to deliver quality
care to patients, create opportunities for patient engagement and increase
efficiency and lower costs.
0.76 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 6
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Censa Pharmaceuticals 19-Apr-16 Cambridge, MA Angel Owner and operator of a pharmaceutical company. The company focuses
on the development and commercialization of therapeutics for orphan
CNS disorders.
1.51 Undisclosed
Axon Therapies 19-Apr-16 New York, NY Early Stage VC Developer of a cardiac-treatment device. The company is a developer of
a novel neuromodulation approach-based bio-electronic device to treat
heart failure.
2.00 Undisclosed
Avadyne Health 19-Apr-16 Moline, IL PE Growth/
Expansion
Provider of revenue cycle management services for the healthcare
industry. The company offers self-pay accounts receivable follow-up
services, including first-party & third-party self-pay billing services and
insurance claims resolution services, which comprise commercial
insurance follow-up, Medicare follow-up and clean-up project services.
Undisclosed MTS Health
Investors
Advantagene 19-Apr-16 Auburndale, MA Angel Operator of a biopharmaceutical company focused on oncology and
immunotherapy. The company focuses on preventing the recurrence and
progression of cancer through the use of therapeutics in oncology and
immunotherapy.
5.02 Undisclosed
Adgero
Biopharmaceuticals
19-Apr-16 Princeton, NJ Angel Developer of a photo dynamic therapy platform for the treatment of
unmet medical needs and for cutaneous metastatic breast cancer
treatment.
3.02 Undisclosed
Novarus Healthcare 18-Apr-16 Charlotte, NC Early Stage VC Developer of software for hospitals. The company develops software for
workforce management, benefits invoices management and patient
engagement.
0.75 Dioko Health
Ventures
Mediprocity 18-Apr-16 Chesterfield, MO Angel Provider of a healthcare messaging platform for doctors and patients.
The company provides an electronic patient health information platform
that protects communications among physicians, healthcare providers
and business associates.
0.18 Undisclosed
Eupraxia
Pharmaceuticals
18-Apr-16 Victoria, Canada Angel Operator of a biotechnology company. The company develops drugs
used for the treatment of arthritis and inflammatory joint diseases,
chronic pains, and diabetic macular edema and posterior uveitis.
0.04 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 7
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Colorado Therapeutics 18-Apr-16 Broomfield, CO Angel Developer of xenogenic biologic tissue matrix products and therapeutic
devices for a broad range of soft tissue reinforcement, regenerative and
vascular applications.
4.30 Undisclosed
Cearna 18-Apr-16 Chicago, IL Angel Provider of plastic surgery recovery products. The company offers a
product named OcuMend that is an ultra-penetrating nanotechnology
embeded with arnica and ledum, leading to speedy recovery of bruising,
pain and swelling caused from facial aesthetics procedures such as
rhinoplasty, blepharoplast, rhytidectomy and dermal filler.
0.66 Undisclosed
ProstaGene 17-Apr-16 Wynnewood, PA Angel Developer of a diagnostic test that distinguishes benign from malignant
prostate cancer. The company's prognostic test defines a group of
patients with poor outcome based on a signature of gene expression in
the patients prostate tumor.
0.40 Undisclosed
Fresca Medical 16-Apr-16 San Clemente, CA Angel Developer of medical devices for treatment of patients suffering from
obstructive sleep apnea diseases.
3.03 Undisclosed
SafeOp Surgical 15-Apr-16 Hunt Valley, MD Early Stage VC Manufacturer of intraoperative neuromonitoring devices that help
caregivers to monitor and prevent nerve damage that can occur during
surgical procedures.
1.75 Undisclosed
PeptiGelDesign 15-Apr-16 Cheshire, United
Kingdom
Seed Round Developer of peptide based hydrogels for biomedical and
biotechnological applications. The company develops peptide based
hydrogel, stem-cell culture and tissue engineering to support
development steps and commercialisation of therapeutic treatments from
in-vitro studies to in-vivo applications.
Undisclosed Deepbridge Capital
MatriTek 15-Apr-16 New York, NY Angel Operator of a life sciences research supply company. The company
specializes in the production of tissue-specific biomaterials that are
derived from natural organ and tissue sources and contain a wealth of
tissue‐specific biochemical factors that make up the native cellular
environment.
1.10 Undisclosed
BioCurity 15-Apr-16 New Smyrna Beach,
FL
Angel Developer of a nanoparticle drug candidate to treat radiation-related
xerostomia and dermatitis.
0.11 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 8
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Aces Health 15-Apr-16 Atlanta, GA Angel Developer of a software for patient data tracking. The company develops
a mobile and Web-based software that captures and tracks patient data
and communication essential to clinical safety and efficacy protocols.
0.08 Undisclosed
TargEDys 14-Apr-16 Rouen, France Early Stage VC Developer of a mechanism to regulate appetite. The company develops
hormone mimetic proteins which helps in regulating the eating behavior
of obese people.
6.44 Seventure Partners,
Pontifax, NCI
Reflexion Medical 14-Apr-16 Hayward, CA Early Stage VC Developer of a targeted radiation therapy system. The company is
developing a biologically-guided radiation therapy system to be used for
treating solid tumors throughout the body.
46.00 KCK Group
Quartet Health 14-Apr-16 New York, NY Early Stage VC Provider of a cloud based behavioral healthcare platform that allows
medical and behavioral health clinicians to work collaboratively on shared
treatment goals and also helps patients to access technology-enabled care.
40.00 GV
Motion Intelligence 14-Apr-16 Ithaca, NY Angel Manufacturer and developer of a medical screening device to enhance
the understanding of sports-related concussions.
3.60 Undisclosed
Imara 14-Apr-16 Cambridge, MA Early Stage VC Developer of therapeutics for diseases involving blood cells. The
company is focused on development of IMR-687, a disease-modifying
therapeutics selected for the treatment of sickle cell disease and other
hemoglobinopathies.
31.00 New Enterprise
Associates, Pfitzer
Venture
Investments,
Lundbeckfond
Eligible 14-Apr-16 Brooklyn, NY Angel Provider of a platform that streamlines insurance eligibility checks for
doctors and patients. The company offers an online platform for
healthcare eligibility queries that lets doctors process queries in real-time.
25.20 Undisclosed
Benefits Science 14-Apr-16 The Woodlands,
TX
Angel Provider of an online healthcare data analytics platform. The company
offers a Web-based platform that analyzes data from employee health-
insurance claims and predicts health risks and thereby helps them to
manage healthcare expenditures.
0.56 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 9
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Sitka Biopharma 13-Apr-16 Vancouver, Canada Seed Round Developer of a novel polymer platform technology for cancer treatment.
The company develops a polymer compound that allows taxane drugs to
adhere to the bladder wall and improves drug absorption for cancer
treatments.
Undisclosed Quark Venture
Oncorus 13-Apr-16 Cambridge, MA Early Stage VC Developer of a next-generation immunotherapy platform. The company
develops next generation oncolytic vectors for the treatment of cancer.
4.61 MPM Capital, other
undisclosed
Maize Analytics 13-Apr-16 Nashville, TN Angel Provider of machine learning software to monitor and protect patient
data. The company provides an auditing system that allows privacy
officers to identify inappropriate accesses to EMR data. The platform
uses machine learning to identify why access occurs, and then filters away
appropriate accesses, leaving a much smaller subset for manual review.
Undisclosed Jim Sohr
Keystone Mobile
Partner
13-Apr-16 Willow Grove, PA Angel Provider of shock wave lithotripsy services. The company operates
mobile units which provides a range of urological care services for
patients.
0.04 Undisclosed
CareDox 13-Apr-16 New York, NY Seed Round Provider of online health records of children to parents. The company
contacts and collects children health records from doctors and displays
data.
4.30 TEXO Ventures,
Prolog Ventures
Qu Biologics 12-Apr-16 Vancouver, Canada Angel Developer of a site specific immunotherapy. The company develops site
specific immunomodulators that stimulate activated innate immune cell
recruitment to the targeted organ or tissue to restore immune function
and treat a range of chronic diseases, including cancer and inflammatory
bowel disease.
3.02 Undisclosed
BioFluidica 12-Apr-16 Chapel Hill, NC Angel Owner and operator of a biotechnology company developing a diagnostic
platform that helps in disease management and diagnosis through
prognosis from blood samples using liquid biopsies for cancer detection.
1.08 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 10
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
NurseGrid 11-Apr-16 Portland, OR Early Stage VC Developer of a mobile application for nurse scheduling in hospitals. The
company offers a suite of scheduling and staffing software that allows
nurses to communicate and share schedules with their colleagues in real-
time.
2.50 Undisclosed
MediQuire 11-Apr-16 New York, NY Early Stage VC Operator of a data analytics platform for primary care clinics. The
company offers a software which enables customers to identify clinical,
operational and financial improvement opportunities and delivers
actionable alerts to clinicians in their daily workflow.
Undisclosed FCA Ventures
Partners
Lumiata 11-Apr-16 San Mateo, CA Early Stage VC Provider of real-time medical science predictive analytics. The company
allows hospital networks, health insurance companies and risk bearing
entities to be able to continuously predict the health, risk and cost of
individuals and populations in real time and at scale. It combines big data
and data science with physician and medical science to deliver hyper-
personalized, actionable analytics.
10.00 Undisclosed
KERANOVA 11-Apr-16 Saint-Étienne,
France
Early Stage VC Designer and developer of instruments for ophthalmic surgery. The
company develops a surgical instrument to reduce the manual
intervention and provide automation in surgical procedures.
4.44 Mérieux
Développement,
CEA Investissement
InnerSpace Neuro
Solutions
11-Apr-16 Tustin, CA Angel Developer of an intracranial pressure monitoring technology system. The
company provides simultaneous ICP monitoring and CSF drainage while
eliminating leveling of a fluid-based system.
2.00 Undisclosed
AbSci 11-Apr-16 Portland, OR Early Stage VC Developer of proprietary engineered Escherichia coli (E. coli) expression
system for production of soluble recombinant monoclonal antibodies
and therapeutic proteins. The company has developed a proprietary
genetically engineered E. coli-based expression system which bypasses
inclusion body formation in the production process of proteins.
5.10 Phoenix Venture
Partners
Thrive Agrobiotics 8-Apr-16 San Francisco, CA Angel Provider of research and development services for nutritive proteins and
gut cell therapy.
6.67 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 11
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
MedDay
Pharmaceuticals
8-Apr-16 Paris, France Early Stage VC Developer of novel drugs targeting brain metabolism for the treatment of
nervous system disorders.
37.78 Edmond de
Rothschild
Investment Partners
Sweetch 7-Apr-16 Jerusalem, Israel Early Stage VC Developer of a mobile application to monitor blood glucose levels. The
company offers a platform for clinical outcome prediction and wellness
prevention intervention for diabetes patients.
3.50 OurCrowd, Philips
HealthVerity 7-Apr-16 Philadelphia, PA Early Stage VC Provider of healthcare data and patient informatics. The company offers
a patient engagement platform by providing healthcare data for research
and strategy applications to healthcare stakeholders.
7.19 Flare Capital
Partners, Greycroft
Partners
Fresh Medical
Laboratories
7-Apr-16 Salt Lake City, UT Angel Owner and operator of a medical device company developing non-
invasive diagnostics. The company develops medical devices for the
purpose of lung cancer which helps to extend lives through the early risk
stratification of lung cancer.
0.52 Undisclosed
Applied BioCode 7-Apr-16 Santa Fe Springs,
CA
Angel Developer of multiplex detection systems. The company provides
Barcoded Magnetic Beads, a digital multiplexing molecular platform that
delivers multiplex analysis for molecular and protein testing needs.
9.26 Undisclosed
Thermosome 6-Apr-16 Planegg/
Martinsried,
Germany
Early Stage VC Developer of novel cancer drugs leveraging its unique platform of
thermosensitive nanocarriers to treat locally advanced solid tumors with
targeted chemotherapy. It also using a novel liposome technology based
on synthetic phospholipids that provides liposomes with prolonged
circulation half-life and ultra-fast release properties.
5.11 Bayern Kapital,
High-Tech
Gründerfonds,
other undisclosed
MedPilot 6-Apr-16 New York, NY Seed Round Provider of a healthcare software tool for patient billing and collections.
The company's software uses data science and behavioral targeting to
recommend patient engagement methods, personalize communications
and resolve outstanding balances.
0.75 Blueprint Health,
Hudson River
Capital Partners,
Tom Hirschfield
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 12
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Jellagen 6-Apr-16 Pembroke Dock,
United Kingdom
Early Stage VC Producer of jellyfish-derived collagen for various clinical applications.
The company sources and supplies medical-grade jellyfish collagen, for
uses that include wound care and biomaterial coatings.
2.18 London Business
Angels
EnsoData 6-Apr-16 Madison, WI Seed Round Developer of software for sleep data analysis. The company develops
software which analyzes and identifies polysomnograph data and
provides auto-scoring and analytics.
0.55 Undisclosed
CoNextions Medical 6-Apr-16 Sandy, UT Angel Producer of medical devices to improve tendon repair outcomes. The
company's devices allow for faster rehabilitation, fewer complications,
and lower long-term costs.
2.50 Undisclosed
Bright Health 6-Apr-16 Minneapolis, MN Early Stage VC Provider of a health insurance service platform. The company partners
with health systems and care partners to provide health plans and a
connected healthcare experience to support relationships between
consumers and care providers.
80.00 Bessemer Venture
Partners, New
Enterprise
Associates
INanoBio 5-Apr-16 Tempe, AZ Angel Developer of a nanosensor technology. The company develops
applications in genome sequencing, healthcare diagnostics and industrial
sensing.
0.43 Undisclosed
BiOp Medical 5-Apr-16 Ramat Gan, Israel Early Stage VC Developer of an innovative real-time screening tool to identify cancerous
and pre-cancerous cells in epithelium tissues. It also enables point-of-care
diagnosis of the entire cervix, generating a real-time map of the cervix.
2.25 Shanghai Creative
Investments
Zipline 4-Apr-16 San Francisco, CA Early Stage VC Provider of drone access to healthcare. The company provides robotic
airplane service that carries vaccines, medicine, blood and medical
supplies to hospitals and health centers to help save patients' lives.
18.00 Sequoia Capital,
Google Ventures,
Standford University
Zavante Therapeutics 4-Apr-16 San Diego, CA Early Stage VC Developer of biopharmaceutical therapies to treat multi-drug resistant
bacteria. The company is developing and plans to commercialize
injectable antibiotics to combat life threatening diseases caused by drug
resistant bacteria with minimal medical options available.
45.73 Frazier Healthcare
Partners, Longitude
Capital
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 13
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Metabomed 4-Apr-16 Yavne, Israel Early Stage VC Operator of a drug-discovery company. The company has developed a
proprietary target-identification platform for cancer that is based on
computational biology and metabolomics.
18.00 Pfizer, Arkin
Holdings, MS
Ventureson
Human Longevity 4-Apr-16 San Diego, CA Early Stage VC Provider of genomics and cell therapy-based diagnostic and therapeutic
technology. The company develops cell-based therapeutics to address age-
related decline in endogenous stem cell function. It concentrates on
cancer, diabetes and obesity, heart and liver diseases and dementia.
220.00 Illumina, Celgene
Entasis Therapeutics 4-Apr-16 Waltham, MA Early Stage VC Developer of antibacterials to treat infectious diseases caused by drug-
resistant bacteria. The company discovers and develops antibacterial
drugs to treat infections and to improve patients’ health and outcomes by
creating life-saving medicines.
50.00 Clarus
Salarius Pharmaceuticals 3-Apr-16 City of Holladay,
UT
Angel Developer of cancer therapies for pediatric, rare and other cancers. 0.78 Undisclosed
NP-C Therapeutics 1-Apr-16 King of Prussia, PA Angel Developer of a treatment therapy to treat lipid storage diseases. The
company develops a treatment therapy using a combination of three
drugs which help to treat lysosomal storage diseases.
0.18 Undisclosed
NeuroFx 1-Apr-16 Fishers, IN Seed Round Developer of adult stem cell derived technology. The company is
developing cell-free therapeutic factor concentrates derived from adult
adipose (fat) stem cells which can be used in non-neurological conditions,
such as musculoskeletal, dermatologic and cardiovascular.
1.89 Undisclosed
Müvr Labs 1-Apr-16 San Francisco, CA Accelerator/
Incubator
Provider of a wearable tracking device for physical surgery that helps
users to measure and complete their physical therapy accurately and
comprehensively. The company also offers a Web-based mobile
application to track the progress of post surgery recovery.
0.02 Y Combinator
Human Data Project 1-Apr-16 San Francisco, CA Accelerator/
Incubator
Developer of a platform that helps in matching patients to clinical trials.
The company's platform imports the medical records and medical history
of patients and searches their database to look for clinical trials with the
same medical conditions.
0.02 Y Combinator
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 14
Monthly Healthcare Review
April 2016
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Lead Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
DalCor 1-Apr-16 Montreal, Canada Early Stage VC Developer and provider of precision medicine to patients through
identification of patient populations, focusing on cardiovascular
medicines.
100.00 Investor Sanderling
Ventures, Andre
Desmarais
Cooper Human Systems 1-Apr-16 Nashua, NH Angel Provider of biomedical engineering services. 0.29 Undisclosed
ConnectHealth 1-Apr-16 Nairobi, Kenya Accelerator/
Incubator
Developer of a telemedicine application that connects patients to a
doctor. The company's software enables prescription and medical advice
delivery of medical consultation with doctors via a mobile device.
0.02 Y Combinator
BillionToOne 1-Apr-16 San Francisco, CA Accelerator/
Incubator
Provider of a pre-natal genetic testing device. The company specializes in
developing a non-invasive fetal genetic testing device to detect and
sequence unborn baby's DNA from mother's blood to check if the baby
has a genetic disease.
0.02 Y Combinator
BenMedica 1-Apr-16 St. Louis, MO Accelerator/
Incubator
Provider of a healthcare cost management platform. The company
enables insurers to communicate with physicians regarding patient’s drug
costs, coverage and pertinent clinical information via the existing
physician office electronic medical record.
0.10 Capital Innovators
Atrin Pharmaceuticals 1-Apr-16 Doylestown, PA Angel Developer of cancer treatment therapies. The company specializes in
developing medications and therapies for the treatment of breast,
pancreatic, lung, ovarian, and colon cancers.
1.50 Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 15
Monthly Healthcare Review
April 2016
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Hi-Tech
Pharmaceuticals
Gaspari Nutrition Lakewood, NJ 28-Apr-16 Manufacturer and retailer of nutrition supplements for athletes. The company
produces dietary supplements for professional athletes and recreational fitness
enthusiasts to improve their performance and physique.
Undisclosed
Neogen Corporation Deoxi
Biotecnologia
Araçatuba, Brazil 27-Apr-16 Provider of molecular biology laboratory services. The company operates as a
molecular biology research firm and provides identification of deoxyribonucleic
acid (DNA) single nucleotide polymorphism (SNP) markers and submicroscopic
chromosomal alterations, using techniques for SNP chip genotyping and next
generation sequencing (NGS) services. It also provides human, animal and plant
genetics research services.
Undisclosed
Inbox Health CakeHealth San Francisco, CA 25-Apr-16 Provider of online healthcare expense-management services where users can
manage their healthcare plans, claims and bills. It also enables users to see their
out-of-pocket spending, the state of deductibles and unused benefits.
Undisclosed
Allergan Topokine Boston, MA 21-Apr-16 Developer of therapies for dermatology and medical aesthetics. The company
develops topical medications for non-invasive contouring of the face and body
and develops non-invasive therapies for subcutaneous fat disorders.
85.00
NorthEdge Capital,
Graham Ewart, Stuart
McA
Direct Healthcare
Services
Caerphilly, United
Kingdom
21-Apr-16 Manufacturer of pressure area care systems for the healthcare industry. The
company develops therapeutic support surfaces which include mattresses,
cushions and overlays and serves acute and community NHS Trusts.
Undisclosed
Stryker Becton Dickinson
& Company
(Vertebral
Augmentation
Solutions Business)
Franklin Lakes, NJ 21-Apr-16 Manufacturer of instruments for back surgery. The company develops vertebral
compression and vertebral augmentation systems used in vertebroplasty and
vertebral augmentation procedures.
Undisclosed
GI Partners, Allscripts
Healthcare
Netsmart
Technologies
Overland Park, KS 19-Apr-16 Provider of enterprise software and software services that support integrated,
coordinated delivery of health services across the spectrum of care.
950.00
Amryt Pharmaceuticals Birken (Germany) Niefern-
Öschelbronn,
Germany
19-Apr-16 Developer and manufacturer of bio-pharmaceutical and dermatology products.
The company develops and manufactures bio-pharmaceuticals, wound healing,
cosmetics and skin care products.
Undisclosed
NanoAntibiotics LAT Pharma Chicago, IL 18-Apr-16 Developer of medicine for ascites due to liver cirrhosis. Undisclosed
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 16
Monthly Healthcare Review
April 2016
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
RJD Green Iosoft Tulsa, OK 18-Apr-16 Developer of medical billing software for claims adjudication, automotive
warranty payments and electronic payments between healthcare service providers
and customers.
Undisclosed
Acorda Therapeutics Biotie Therapies Turku, Finland 18-Apr-16 Provider of drug development services focused on products for
neurodegenerative and psychiatric disorders. Its products portfolio includes,
Selincro, Tozadenant (SYN115), NRL-1, Nepicastat (SYN117), BTT-1023 and
SYN120.
363.00
WuXi AppTec Co Crelux Martinsried,
Germany
15-Apr-16 Provider of drug research and discovery services. The company engages in
discovery of proteins which are used for biophysical screening and producing
protein crystals that are used in drugs.
Undisclosed
Ethicon NeuWave Medical Madison, WI 14-Apr-16 Developer of energy based invasive medical devices. The company manufactures
and markets minimally invasive soft-tissue microwave ablation systems.
Undisclosed
athenahealth Arsenal Health Watertown, MA 14-Apr-16 Developer of time-management software for healthcare professionals. The
company offers an application designed to help doctors predict patient no-shows
to allow better management of daily appointments and patient scheduling.
Undisclosed
Adamis
Pharmaceuticals
US Compounding Conway, AR 12-Apr-16 Operator of a drug compounding outsourcing facility. The company provides
bespoke medications, such as corticosteroids and hormone replacement therapies.
10.20
Predictive Therapeutics Renovo Biotech Salt Lake City, UT 12-Apr-16 Provider of stem cell research and development services. The company is focused
on the development, processing and distribution of innovative allograft tissues,
stem cells and biomaterials for the treatment of serious and debilitating diseases.
Undisclosed
Maven Capital Partners,
Patrick Sparkes
Westfield Medical Radstock, United
Kingdom
11-Apr-16 Manufacturer of one-time-use sterilization packaging products. The company's
range of products include heat seal sterilization bags, sterilization reels,
sterilization pouches and hospital sterilization packaging products.
17.08
Ossur Touch Bionics Livingston, United
Kingdom
11-Apr-16 Provider of prosthetic technologies and supporting services. The company's
products include myoelectric prosthetic hand and prosthetic finger technology, as
well as passive silicone prostheses that matches the natural appearance of the
wearer.
39.14
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 17
Monthly Healthcare Review
April 2016
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Aché Laboratórios
Farmacêuticos
Nortis Farmacêutica Londrina, Brazil 11-Apr-16 Manufacturer of antibiotics and non-prescription medicines. The company
specializes in the manufacture of cephalosporin antibiotics, nutraceuticals and
blister packs.
Undisclosed
Recipharm Nitin Lifesciences Karnal, India 11-Apr-16 Manufacturer of sterile injectables. The company specializes in manufacturing
liquid ampoules, liquid vials, sterile dry powder, multidose eye/ear drops and
lyophilized vials.
100.17
International Business
Machine
Truven Health
Analytics
Ann Arbor, MI 8-Apr-16 Operator of a healthcare analytics company. The company provides data, analytics
and performance benchmarking services. It serves the global healthcare industry
through utilization of its data assets and analytic technology and expertise.
2600.00
Stryker SafeWire Cooper City, FL 8-Apr-16 Provider of surgical devices. The company designs, develops and markets medical
devices to facilitate minimally invasive surgical procedures.
Undisclosed
Diversis Capital CaligorRx Secaucus, NJ 8-Apr-16 Distributor of comparator drugs, rescue medications, combination therapies,
ancillary supplies and logistical support for worldwide clinical trials.
Undisclosed
4d pharma BIOMAR Microbial
Technologies
León, Spain 8-Apr-16 Developer of new products in the pharmaceutical sector, bio-energy industry and
food production industry. The company focuses on collaborations with other
biotech and pharmaceutical companies in different therapeutic areas such as
cancer, CNS, anti-infectives and immunology.
3.33
Evonik Alkion
BioInnovations
Evry, France 8-Apr-16 Manufacturer of drugs for cancer treatments. The company's technology allows
production of complex pharmacologically active compounds which are only
present in plant species.
Undisclosed
Mach7 Technologies 3D Medical
(Medical
Technology)
Port Melbourne,
Australia
8-Apr-16 Provider of medical printing services. The company is engaged in offering medical
specific three-dimensional (3D) printing and holographic projection services.
44.90
Adavium Medical Hemogram
Industria e
Comercio
São Paulo, Brazil 7-Apr-16 Developer of lab devices for assessing and processing blood products. The
company is the developer of a haematological cell analyzer, which offers
evaluation of white and red blood cells, as well as separating constituent parts of
blood, to be processed as reagents.
Undisclosed
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 18
Monthly Healthcare Review
April 2016
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Lightbeam Health
Solutions
Browsersoft Shawnee, KS 6-Apr-16 Provider of a health information exchange (HIE). The company provides a system
which enables healthcare communities to exchange data from disparate systems
enabling providers to have the most comprehensive and up to date patient
information.
Undisclosed
SwervePay StatPayMD Chicago, IL 5-Apr-16 Provider of high-deductible health plans online. The company's platform allows
patients to make appointments online and provides pre-negotiated prices for the
medical procedures.
Undisclosed
Trajan Scientific LEAP Technologies
(Part of the Trajan
Family)
Carrboro, NC 5-Apr-16 Provider of automated sample preparation systems. The company offers HDX,
Benchtop NMR, dispensers, gas chromatography, pumps, research and
development, life science, pharmaceutical, polymer, food processing, forensic and
academic sectors.
Undisclosed
Strides Shasun Moberg Pharma
(Three Brands)
Bromma, Sweden 4-Apr-16 Provider of Vanquish, a pain relieving cream and tablet, and Fergon, an iron
supplement.
10.00
Citius Pharmaceuticals Leonard-Meron
Biosciences
Cranford, NJ 4-Apr-16 Provider of drug development services. The company operates as a biotechnology
company engaged in development of a antibiotic lock to treat catheter-related
bloodstream infections.
Undisclosed
Medidata Solutions Intelemage Cincinnati, OH 4-Apr-16 Developer of software products for the medical and pharmaceutical sector. The
company is engaged in the development and designing of software systems which
are utilized for image transfers and exchange activities, advanced clinical data
workflow management and electronic data capture.
Undisclosed
Positivo Informatica Hi Technologies Curitiba, Brazil 4-Apr-16 Manufacturer of health monitoring devices. The company offers biomedical
equipment, electrocardiogram machines and telemedicine technology to medical
institutions, hospitals and clinics.
Undisclosed
Segulah Hermes Medical
Solutions
Stockholm, Sweden 4-Apr-16 Provider of systems and software services for the medical industry. The company
engages in integration, visualization, processing and archiving of image data from
different modaliter and manufacturer of scanning equipment in molecular imaging
and radiology.
Undisclosed
CooperSurgical Genesis Genetics Plymouth, MI 4-Apr-16 Provider of genetic testing services. The company offers services to identify the
correct number of chromosomes and DNA that contributes to problematic health
issues.
60.00
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 19
Monthly Healthcare Review
April 2016
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
KAI Innovations Trimara Ottawa, Canada 1-Apr-16 Developer and distributor of medical software suites. The company provides a
software which specializes in electronic medical records, network management,
desktop management, database management, disaster recovery and also offers
services such as web development and project management.
Undisclosed
American Capital
Equity, New Canaan
Funding
Science Care Phoenix, AZ 1-Apr-16 Operator of a non-transplant human tissue bank. The company offers physician
training, surgical device development, neurological research and drug discovery
services.
Undisclosed
Stryker Corporation Sage Products Cary, IL 1-Apr-16 Manufacturer of healthcare products. The company produces cosmetics, over-the-
counter drugs and pharmaceuticals.
2775.00
THERAMetrics Relief Therapeutics Genève,
Switzerland
1-Apr-16 Developer of therapies focused on unmet medical needs. The company develops
treatments that deal mainly with degeneration of the peripheral nervous system.
Undisclosed
Bristol-Myers Squibb Padlock
Therapeutics
Cambridge, MA 1-Apr-16 Provider and developer of novel drugs. This company is focused on discovering
novel therapeutics that target protein arginine deiminases an emerging class of
enzymes with roles in autoimmunity and epigenetic control.
600.00
Biotelemetry Delta Danish
Electronics, Light
and Acoustics
(ePatch Division)
Hørsholm,
Denmark
1-Apr-16 Manufacturer of cardiac monitoring devices. The company is engaged in
production and distribution of cardiac monitors utilizing proprietary patch and
sensor technology.
9.00
Gentherm Cincinnati Sub-Zero
Products
Cincinnati, OH 1-Apr-16 Manufacturer of temperature management equipment. The company is engaged in
the production and distribution of patient temperature systems for the health care
industry and custom environmental test chambers used by a wide range of
industrial manufacturing companies for product testing.
Undisclosed
Repligen Atoll Weingarten,
Germany
1-Apr-16 Manufacturer of pre-packed chromatography columns. The company specializes
in the manufacturing and distribution of MediaScout, a chromatographic column
technology platform used in the process development and clinical manufacturing
of biologic drugs.
26.11
Compiled by: Morgan Reape
Sources: PitchBook, Wall Street Journal, SEC Filings, Company Press Releases, fiercebiotech.com, PE HUB, and biospace.com 20